On February 24, 2017, Biomedx Inc. paid Visualant, Incorporated (the Company) $290,766.66 in full payment of the Original Issue Discount Convertible Promissory Note purchased from Pulse Biologics dated November 2, 2016.
On February 24, 2016, The Company paid $113,544.44 in full payment of an Original Issue Discount Convertible Promissory Note issued to an accredited investor on November 1, 2016.
Item 3.02 Unregistered Sales of Equity Securities.
On February 24, 2017, the holder of an Original Issue Discount Convertible Promissory Note issued on November 1, 2016 converted the principal and outstanding interest of $227,088 into 283,861 shares of the Companys Series D Preferred Stock and a five-year warrant to purchase 283,861 shares of common stoc k.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant: VISUALANT, INCORPORATED
Jeff Wilson, CFO
March 1, 2017
makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Exempt Offering of Securities, item 06b - May 25, 2018
VISUALANT: Press Release Dated May 25, 2018 - May 25, 2018
Know Labs Appoints (Ret.) Admiral Bill Owens to its Board of Directors - May 24, 2018
Visualant, Incorporated Announces Name Change to Know Labs, Inc. and Files to Trade under New Stock Symbol - May 2, 2018